Moclamine

Moclamine may be available in the countries listed below.

Ingredient matches for Moclamine

Moclobemide

Moclobemide is reported as an ingredient of Moclamine in the following countries:

• France

International Drug Name Search

Sifrol

Sifrol may be available in the countries listed below.

Ingredient matches for Sifrol

Pramipexole

Pramipexole is reported as an ingredient of Sifrol in the following countries:

• Malaysia

Pramipexole dihydrochloride monohydrate (a derivative of Pramipexole) is reported as an ingredient of Sifrol in the following countries:

• Argentina


• Australia


• Austria


• Bahrain


• Belgium


• Brazil


• Chile


• Cyprus


• Denmark


• Egypt


• Finland


• France


• Germany


• Iceland


• Indonesia


• Iraq


• Jordan


• Kuwait


• Lebanon


• Libya


• Luxembourg


• Mexico


• Netherlands


• Norway


• Oman


• Qatar


• Saudi Arabia


• Singapore


• Sweden


• Switzerland


• Thailand


• United Arab Emirates


• Venezuela


• Yemen

International Drug Name Search

Iwamet

Iwamet may be available in the countries listed below.

Ingredient matches for Iwamet

Cimetidine

Cimetidine is reported as an ingredient of Iwamet in the following countries:

• Myanmar


• Thailand

International Drug Name Search

Betadrin

Betadrin may be available in the countries listed below.

Ingredient matches for Betadrin

Diphenhydramine

Diphenhydramine hydrochloride (a derivative of Diphenhydramine) is reported as an ingredient of Betadrin in the following countries:

• Poland

Naphazoline

Naphazoline nitrate (a derivative of Naphazoline) is reported as an ingredient of Betadrin in the following countries:

• Poland

International Drug Name Search

Tamibarotene

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0094497-51-5

Chemical Formula

C22-H25-N-O3

Molecular Weight

351

Therapeutic Categories

Antineoplastic agent

Antipsoriatic

Chemical Names

N-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)terephthalamic acid (WHO)

p-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthylcarbamoyl)benzoic acid

4-[(1,1,4,4-tetramethyltetralin-6-yl)carbamoyl]benzoic acid (IUPAC)

4-[(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid (JAN)

Foreign Names

• Tamibarotenum (Latin)
• Tamibaroten (German)
• Tamibarotène (French)
• Tamibaroteno (Spanish)

Generic Names

• Tamibarotene (OS: JAN)
• AM-80 (IS)
• INNO-507 (IS)
• NSC 608000 (IS)
• RR-110 (IS)
• TM-411 (IS)
• TOS-80 (IS)
• UNII-08V52GZ3H9 (IS)
• Z-208 (IS)

Brand Name

• Amnolake
  Toko Pharmaceutical, Japan

International Drug Name Search

Glossary

IUPAC	International Union of Pure and Applied Chemistry
IS	Inofficial Synonym
JAN	Japanese Accepted Name
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Monensin

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Monensin

Monensin

Monensin (BAN, USAN) is also known as Monensin (Rec.INN)

Bacitracin

Bacitracin methylene disalicylate (a derivative of Bacitracin) is reported as an ingredient of Monensin in the following countries:

• United States

Bacitracin zinc salt (a derivative of Bacitracin) is reported as an ingredient of Monensin in the following countries:

• United States

Bambermycin

Bambermycin is reported as an ingredient of Monensin in the following countries:

• United States

International Drug Name Search

Glossary

BAN	British Approved Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Mabuterol Hydrochloride

Mabuterol Hydrochloride may be available in the countries listed below.

Ingredient matches for Mabuterol Hydrochloride

Mabuterol

Mabuterol Hydrochloride (JAN) is also known as Mabuterol (Rec.INN)

International Drug Name Search

Glossary

JAN	Japanese Accepted Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.